Diseases of the Pancreas Flashcards

1
Q

Glasgow criteria for prognosis in acute pancreatitis

A

• Age > 55 years
• P O 2 < 8 kPa (60 mmHg)
• White blood cell count > 15 × 10 9 /L
• Albumin < 32 g/L (3.2 g/dL)
• Serum calcium < 2 mmol/L (8 mg/dL) (corrected)
• Glucose > 10 mmol/L (180 mg/dL)
• Urea > 16 mmol/L (45 mg/dL) (after rehydration)
• Alanine aminotransferase > 200 U/L
• Lactate dehydrogenase > 600 U/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Initial assessment that predicts severe pancreatitis

A

• Clinical impression of severity
• Body mass index > 30 kg/m 2
• Pleural effusion on chest X-ray
• APACHE II score > 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Features that predict severe pancreatitis at 24 hours after admission

A

• Clinical impression of severity
• APACHE II score > 8
• Glasgow score > 3
• Persisting organ failure, especially if multiple
• CRP > 150 mg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Features that predict severe pancreatitis at 48 hours after admission

A

• Clinical impression of severity
• Glasgow score > 3
• CRP > 150 mg/L
• Persisting organ failure for 48 hours
• Multiple or progressive organ failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of acute pancreatitis

A

-Autodigestion of pancreatic tissue by the pancreatic enzymes, leading to necrosis

-Pancreatic duct obstruction (common bile duct stones, tumours)
-Reflux of bile or duodenal contents into pancreatic ducts (sphincter of Oddi dysfunction)
-Hyperstimulation of pancreas (alcohol, triglycerides)
-Defective intracellular transport and secretion of pancreatic zymogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Triggers of acute pancreatitis

A

-Alcohol
-Gallstones
-Pancreatic duct obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common causes of acute pancreatitis

A

• Gallstones
• Alcohol
• Idiopathic causes
• Post-ERCP (endoscopic retrograde cholangiopancreatography)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rare causes of acute pancreatitis

A

• Post-surgical (abdominal, cardiopulmonary bypass)
• Trauma
• Drugs (azathioprine/mercaptopurine, thiazide diuretics, sodium valproate)
• Metabolic (hypercalcaemia, hypertriglyceridaemia)
• Pancreas divisum
• Sphincter of Oddi dysfunction
• Infection (mumps, Coxsackie virus)
• Hereditary factors
• Renal failure
• Organ transplantation (kidney, liver)
• Severe hypothermia
• Petrochemical exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GET SMASHED

A

Gallstones
Ethanol
Trauma
Steroids
Mumps (other viruses include Coxsackie B)
Autoimmune (e.g. polyarteritis nodosa) Ascaris infection
Scorpion venom
Hypertriglyceridaemia, Hyperchylomicronaemia, Hypercalcaemia, Hypothermia
ERCP
Drugs (azathioprine, mesalazine*, didanosine, bendroflumethiazide, furosemide, pentamidine, steroids, sodium valproate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical features of acute pancreatitis

A

-Severe, constant upper epigastric pain, of increasing intensity over 15–60 minutes, which radiates to the back.
-Nausea and vomiting are common.
-Marked epigastric tenderness, but in the early stages, guarding and rebound tenderness are absent because the inflammation is principally retroperitoneal.
-Bowel sounds become quiet or absent as paralytic ileus develops.
-In severe cases, the patient becomes hypoxic and develops hypovolaemic shock with oliguria.
-Discoloration of the flanks (Grey Turner’s sign) or the periumbilical region (Cullen’s sign) is a feature of severe pancreatitis with haemorrhage.
-Low grade fever

-Rarely, ischaemic Purtscher retinopathy: temporary or permanent blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Differential diagnosis of acute pancreatitis

A

-Perforated viscus
-Acute cholecystitis
-Myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pancreatic complications of acute pancreatitis

A

-Necrosis
=Non-viable pancreatic tissue and peripancreatic tissue death; frequently infected

-Pseudocyst
=Disruption of pancreatic ducts
=Walled with granulation or fibrous tissue, 4+ weeks after attack, mostly retrogastric, elevate amylase, CT ERCP MRI USS, observed for 12 weeks as 50% resolve
=Endoscopic or surgical cystogastromy or aspiration

-Pancreatic ascites or pleural effusion
=disruption of pancreatic ducts

-Abscess
=Circumscribed collection of pus close to the pancreas and containing little or no pancreatic necrotic tissue
=Transgastric drainage is one method of treatment, endoscopic drainage is an alternative

-Peripancreatic fluid collections
=25%, lack wall of granulation or fibrous tissue, may resolve or develop into pseudocysts or abscesses, avoid aspiration and drainage

-Haemorrhage
=Infected necrosis may involve vascular structures with resultant haemorrhage that may occur de novo or as a result of surgical necrosectomy.
=When retroperitoneal haemorrhage occurs Grey Turner’s sign may be identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Systemic complications of acute pancreatitis

A

-Systemic inflammatory response syndrome (SIRS/ ARDS)
=Increased vascular permeability from cytokine, platelet-aggregating factor and kinin release

-Hypoxia
=Acute respiratory distress syndrome (ARDS) due to microthrombi in pulmonary vessels

-Hyperglycaemia
=Disruption of islets of Langerhans with altered insulin/glucagon release

-Hypocalcaemia
=Sequestration of calcium in fat necrosis, fall in ionised calcium

-Reduced serum albumin concentration
=Increased capillary permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GI complications of acute pancreatitis

A

-Upper gastrointestinal bleeding
=Gastric or duodenal erosions

-Variceal haemorrhage
=Splenic or portal vein thrombosis

-Erosion into colon
=Erosion by pancreatic pseudocyst

-Duodenal obstruction
=Compression by pancreatic mass

-Obstructive jaundice
=Compression of common bile duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe pancreatic pseudocysts

A

-Pancreatic fluid collection= A collection of fluid and debris may develop in the lesser sac, following inflammatory rupture of the pancreatic duct
-It is initially contained within a poorly defined, fragile wall of granulation tissue, which matures over a 6-week period to form a fibrous capsule.
-Such ‘pseudocysts’ are common and usually asymptomatic, resolving as the pancreatitis recovers.
-Pseudocysts greater than 6 cm in diameter seldom disappear spontaneously and can cause constant abdominal pain and compress or erode surrounding structures, including blood vessels, to form pseudoaneurysms.
-Large pseudocysts can be detected clinically as a palpable abdominal mass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does pancreatic ascites occur?

A

-Fluid leaks from a disrupted pancreatic duct into the peritoneal cavity.
-Leakage into the thoracic cavity can result in a pleural effusion or a pleuro-pancreatic fistula.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Investigations of acute pancreatitis

A

-Raised serum amylase (>x3 normal) or lipase useful for late presentations >24 hours) concentrations and ultrasound or CT evidence of pancreatic swelling.
=a diagnosis of acute pancreatits can be made without imaging if characteristic pain + amylase/lipase > 3 times normal level
=however, early ultrasound imaging is important to assess the aetiology as this may affect management - e.g. patients with gallstones/biliary obstruction
=other options include contrast-enhanced CT

-Plain X-rays exclude perforation or obstruction and identify pulmonary complications.
-Amylase concentrations may have returned to normal if measured 24–48 hours after onset
-A persistently elevated serum amylase concentration suggests pseudocyst formation
-Peritoneal amylase concentrations are massively elevated in pancreatic ascites.
-Serum lipase measurements =greater diagnostic accuracy for acute pancreatitis.

-Ultrasound to confirm diagnosis, although in the earlier stages the gland may not be grossly swollen.

-Contrast-enhanced pancreatic CT performed 6–10 days after admission can be useful in assessing viability of the pancreas if persisting organ failure, sepsis or clinical deterioration is present (pancreatic necrosis)
=Decreased pancreatic enhancement
=Gas suggests infection and impending abscess formation, in which case percutaneous aspiration of material for bacterial culture should be carried out and appropriate antibiotics prescribed

18
Q

Management of acute pancreatitis

A

-Fluid resuscitation
=Aggressive early hydration with crystalloids. In severe cases 3-6 litres of third space fluid loss may occur
=Aim for a urine output of > 0.5mls/kg/hr
=May also help relieve pain by reducing lactic acidosis

-Analgesia
=Pain may be severe so this is a key priority of care
=Intravenous opioids are normally required to adequately control the pain

-Nutrition
=Patients should not routinely be made ‘nil-by-mouth’ unless there is a clear reason e.g. the patient is vomiting
=Enteral nutrition should be offered to anyone with moderately severe or severe acute pancreatitis within 72 hours of presentation
=Parental nutrition should only be used if enteral nutrition has failed or is contraindicated

-Role of antibiotics
=NICE state the following: ‘Do not offer prophylactic antimicrobials to people with acute pancreatitis’
=Potential indications include infected pancreatic necrosis

-Role of surgery
=Patients with acute pancreatitis due to gallstones should undergo early cholecystectomy
=Patients with obstructed biliary system due to stones should undergo early ERCP
=Patients who fail to settle with necrosis and have worsening organ dysfunction may require debridement, fine needle aspiration is still used by some
=Patients with infected necrosis should undergo either radiological drainage or surgical necrosectomy. The choice of procedure depends upon local expertise

19
Q

Management in ITU for acute pancreatitis

A

-Opiate analgesics
-Hypovolaemia corrected using normal saline/ other crystalloids.
-Central venous line and urinary catheter= monitor patients with shock.
-Oxygen for hypoxic patients,
-SIRS= ventilatory support
-Hyperglycaemia corrected using insulin
-Hypocalcaemia by intravenous calcium injection.
-Nasogastric aspiration= paralytic ileus
-Enteral feeding in severely catabolic state
=Decreases endotoxaemia and reduce systemic complications.
-Prophylaxis of thromboembolism with subcutaneous low-molecular-weight heparin
-Infected necrosis is treated with antibiotics that penetrate necrotic tissue

20
Q

Management of patients who present with cholangitis or jaundice (in association with severe acute pancreatitis)

A

-Urgent ERCP to diagnose and treat choledocholithiasis.
-Biliary imaging (using MRCP or EUS) can be carried out after the acute phase has resolved.
-If LFTs return to normal and ultrasound has not demonstrated a dilated biliary tree, laparoscopic cholecystectomy
-Cholecystectomy should be undertaken within 2 weeks of resolution of pancreatitis
-Patients with infected pancreatic necrosis or pancreatic abscess require urgent endoscopic drainage or minimally invasive retroperitoneal pancreatic (MIRP) necrosectomy to debride all cavities of necrotic material.
-Pancreatic pseudocysts can be treated by drainage into the stomach or duodenum.

21
Q

Describe chronic pancreatitis

A

-Chronic inflammatory disease char­acterised by
=fibrosis
=destruction of exocrine pancreatic tissue.
-Diabetes mellitus occurs in advanced cases because the islets of Langerhans are involved

22
Q

Causes of chronic pancreatitis- TIGARO

A

-Toxic-metabolic
-Idiopathic (tropical/ early-late onset
-Genetic (CF, haemochromatosis)
-Autoimmune
-Recurrent and severe acute pancreatitis (post-necrotic)
-Obstructive (ductal, tumours, stones, structural)

Around 80% of cases are due to alcohol excess with up to 20% of cases being unexplained.

23
Q

Toxic-metabolic causes of chronic pancreatitis

A

-Alcohol
-Tobacco
-Hypercalcaemia
-CKD

24
Q

Genetic causes of chronic pancreatitis

A

-Hereditary pancreatitis (cationic trypsinogen mutation)
-SPINK-1 mutation
-Cystic fibrosis

25
Obstructive causes of chronic pancreatitis
-Ductal adenocarcinoma -Intraductal papillary mucinous neoplasia -Pancreas dividum -Sphincter of Oddi stenosis
26
Mechanisms of chronic pancreatitis
-Oxidative stress -Toxic-metabolic -Necrosis-fibrosis -Recurrent acute pancreatitis -Duct obstruction
27
Clinical features of chronic pancreatitis
-Middle-aged alcoholic men -Almost all present with abdominal pain. -In 50%, this occurs as episodes of ‘acute pancreatitis’ -Relentless, slowly progressive chronic pain without acute exacerbations affects 35% of patients, while the remainder have no pain but present with diarrhoea. -Pain is due to a combination of increased pressure within the pancreatic ducts and direct involvement of peripancreatic nerves by the inflammatory process. =Relieved by leaning forwards or by drinking alcohol, worse 15-30 minutes after meal -Weight loss is common and results from a combination of anorexia, avoidance of food because of post-prandial pain, malabsorption and/or diabetes. =Steatorrhoea occurs when more than 90% of the exocrine tissue has been destroyed; protein malabsorption develops only in the most advanced cases. 5-25 years after pain onset -Overall, 30% of patients have (secondary) diabetes but this figure rises to 70% in those with chronic calcific pancreatitis. 20 years later -Physical examination reveals a thin, malnourished patient with epigastric tenderness. =Skin pigmentation over the abdomen and back is common and results from chronic use of a hot water bottle (erythema ab igne). =Many patients have features of other alcohol- and smoking-related diseases.
28
Complications of chronic pancreatitis
• Pseudocysts and pancreatic ascites, which occur in both acute and chronic pancreatitis • Obstructive jaundice due to benign stricture of the common bile duct as it passes through the diseased pancreas • Duodenal stenosis • Portal or splenic vein thrombosis leading to segmental portal hypertension and gastric varices • Peptic ulcer
29
Investigations of chronic pancreatitis
-Tests to establish the diagnosis • Ultrasound • Computed tomography (may show atrophy, calcification or ductal dilatation) • Abdominal X-ray (may show calcification) • Magnetic resonance cholangiopancreatography • Endoscopic ultrasound -Tests to define pancreatic function • Collection of pure pancreatic juice after secretin injection (gold standard but invasive and seldom used) • Pancreolauryl test • Faecal pancreatic elastase -Tests to demonstrate anatomy prior to surgery • Magnetic resonance cholangiopancreatography
30
Intervention in chronic pancreatitis
-Endoscopic therapy • Dilatation or stenting of pancreatic duct strictures • Removal of calculi (mechanical or shock-wave lithotripsy) • Drainage of pseudocysts -Surgical methods • Partial pancreatic resection, preserving the duodenum • Pancreatico-jejunostomy
31
Management of chronic pancreatitis
-Alcohol misuse= avoidance -Pain relief =NSAIDs =Opiates =Pregabalin and tricyclic antidepressants at low dose =Oral pancreatic enzyme supplements suppress pancreatic secretion- reduces analgesic consumption -Malabsorption =Dietary fat restriction (with supplementary medium-chain triglyceride therapy in malnourished patients) =PPI optimised duodenal pH for pancreatic enzyme activity
32
Describe autoimmune pancreatitis
-Form of chronic pancreatitis that can mimic cancer, but which responds to glucocorticoids. -Characterised by abdominal pain, weight loss or obstructive jaundice, without acute attacks of pancreatitis. -Increased serum IgG or IgG4 and the presence of other autoantibodies. -Imaging= diffusely enlarged pancreas, narrowing of the pancreatic duct and stricturing of the lower bile duct. -AIP may occur alone or with other autoimmune disorders, such as Sjögren's syndrome, primary sclerosing cholangitis or IBD. -The response to glucocorticoids is usually excellent but some patients require azathioprine.
33
Describe adenocarcinomas of the pancreas
-80/90% pancreatic neoplasms arising from pancreatic duct, typically at the head of the pancreas -Involve local structures and metastasise to regional lymph nodes -Advanced disease at time of presentation non-specific presentation -Men x2 -Associated with increasing age, smoking, chronic pancreatitis -5-10% patients' genetic predisposition -Survival 3-5% -6-10 months locally advanced disease, 3-5 months with metastases
34
Genetic predisposition to adenocarcinoma of the pancreas
-Hereditary pancreatitis -HNPCC -Familial atypical mole multiple melanoma syndrome (FAMMM)
35
Associations with pancreatic cancer
-Increasing age -Smoking -Diabetes -Chronic pancreatitis (alcohol does not appear an independent risk factor though) -Hereditary non-polyposis colorectal carcinoma -Multiple endocrine neoplasia -BRCA2 gene -KRAS gene mutation
36
Neuro-endocrine tumour of pancreas
-Grow more slowly -Better prognosis
37
Clinical features of adenocarcinoma of pancreas
-Asymptomatic until advanced stage =Central epigastric abdominal pain (invasion of coeliac plexus, incessant and gnawing, radiates from upper abdomen to back, eased by bending forward) =Weight loss, anorexia =Obstructive painless jaundice (involvement of common bile duct, with severe pruritus)- pale stools, dark urine, pruritis, cholestatic LFT -Some diarrhoea, vomiting from duodenal obstruction, DM, recurrent venous thrombosis, acute pancreatitis or depression =Trousseau sign (migratory thrombophlebitis) =Steatorrhoea (loss of exocrine function) =DM (loss of endocrine) =Atypical back pain -Physical Examination =Weight loss =Abdominal mass due to tumour itself (hepatomegaly from mets, palpable gallbladder, epigastric mass) =Courvoisier's sign: palpable gallbladder in jaundice consequence of distal biliary obstruction by a pancreatic cancer
38
Investigations of adenocarcinoma of the pancreas
-Ultrasound and contrast-enhanced high resolution CT first line is diagnosis suspected =Double duct sign (dilation) -EUS/laparoscopy with ultrasound defines tumour size, involvement of blood vessels and metastatic spread -MRCP, ERCP (relieve obstructive jaundice)
39
Management of adenocarcinoma of the pancreas
-Surgical resection= 5-year survival 12%: Whipples (results in dumping syndrome, peptic ulcer disease) -Improved survival with adjuvant chemotherapy using gemcitabine -ERCP with stenting for palliation -Only 10-15% resectable as locally advanced -Palliative =Analgesics/ coeliac plexus neurolysis
40
Incidental pancreatic masses
-Cystic neoplasms =rarely malignant and do not require surgery =Mucinous cysts more in women usually in pancreatic tail =Aspiration, measuring CEA and amylase concentrations determine mucinous or not -Mucinous lesions resected -Intraductal papillary mucinous neoplasia (IPMN) =elderly men =main pancreatic duct with marked dilation and plugs of mucous =pre-malignant but indolent condition